Loading...
Genworth Financial Inc (GNW) is not a strong buy for a beginner, long-term investor at this time. While the company has stable revenue and some positive developments, the technical indicators are neutral, and there are no strong proprietary trading signals or clear catalysts to suggest immediate upside potential. The stock is better suited for monitoring rather than immediate investment.
The MACD is below 0 and negatively contracting, indicating a lack of bullish momentum. RSI is neutral at 48.293, and moving averages are converging, suggesting no clear trend. The stock is trading near its pivot level of 8.688, with resistance at 9.074 and support at 8.303. Overall, the technical indicators are neutral.

Genworth received $407 million in cash from its stake in Enact, enabling significant stock repurchases.
CareScout's expansion to cover 97% of the U.S. senior population demonstrates growth in its service offerings.
Stable revenue of $1.78 billion in Q4 2025 reflects consistent operational performance.
Net income dropped significantly to $2 million in Q4 2025, indicating profitability challenges.
Operating income decreased from $15 million to $8 million YoY, showing ongoing operational difficulties.
Net investment income declined, suggesting weaker returns on investments.
In Q4 2025, revenue increased marginally by 0.39% YoY to $1.784 billion, but net income dropped significantly to $2 million, down 300% YoY. EPS remained flat at $0.01. While premiums increased slightly, net investment income declined, highlighting challenges in profitability.
Analysts see Genworth as a deep value opportunity with a cautiously optimistic outlook. However, there are no recent upgrades or significant changes in price targets to suggest strong momentum.